Evidence map›Paper›PMID 34458746›Full record

ArticleRSC chemical biology2020

Macrocyclic peptides that inhibit Wnt signalling

Manuel E Otero-Ramirez, Kyoko Matoba, Emiko Mihara, Toby Passioura, Junichi Takagi, Hiroaki Suga

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Manuel E Otero-RamirezDepartment of Chemistry, Graduate School of Science, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan hsuga@chem.s.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-8296-9733
Kyoko MatobaLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University 3-2 Yamadaoka Suita-shi Osaka 565-0871 Japan takagi@protein.osaka-u.ac.jp.ORCID https://orcid.org/0000-0001-7434-172X
Emiko MiharaLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University 3-2 Yamadaoka Suita-shi Osaka 565-0871 Japan takagi@protein.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-9127-8643
Toby PassiouraDepartment of Chemistry, Graduate School of Science, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan hsuga@chem.s.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-6089-5067
Junichi TakagiLaboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University 3-2 Yamadaoka Suita-shi Osaka 565-0871 Japan takagi@protein.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-1219-475X
Hiroaki SugaDepartment of Chemistry, Graduate School of Science, The University of Tokyo 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033 Japan hsuga@chem.s.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-5298-9186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we report

Identifiers

PMID34458746
PMCPMC8382136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.